T1	Participants 22 50	children with acute leukemia
T2	Participants 54 84	Pediatric Oncology Group study
T3	Participants 87 238	One hundred four children with advanced leukemia in relapse (74 with acute lymphocytic leukemia [ALL] and 30 with acute nonlymphocytic leukemia [ANLL])
